Probiotics as Adjuvants to Standard <i>Helicobacter pylori</i> Treatment: Evidence for the Use of Lacidofil^®, an Established Blend of Thoroughly Characterized Strains

<i>Helicobacter pylori</i> (<i>H. pylori</i>) is a bacterial pathogen that infects half of the world population. While standard treatment was initially effective, eradication rates have declined over the last 20 to 30 years, and the use of adjuvants, such as probiotic supplements, has been suggested...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Noémie Auclair-Ouellet, Annie Tremblay, Ola Kassem, Sara E. Caballero-Calero, Stéphane Bronner, Sylvie Binda
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2025-09-01
Edice:	Microorganisms
Témata:	<i>Helicobacter pylori</i> (<i>H. pylori</i>) treatment probiotics <i>Lacticaseibacillus rhamnosus</i> Rosell<sup>®</sup>-11 <i>Lactobacillus helveticus</i> Rosell<sup>®</sup>-52
On-line přístup:	https://www.mdpi.com/2076-2607/13/10/2223
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!